Back to Schedule
FinalSunday, Sep 20, 2026 · 3:30 PM
Nameless74
Final
Team In The Lab71
Team Comparison
NamelessTeam In The Lab
Top Performers
#1 Parminder Mangat
Nameless
32PTS
2REB
4AST
STL 5BLK 1FG 14-38 (36.8%)
#10 Player #10
Team In The Lab
23PTS
12REB
2AST
STL 3BLK 1FG 10-18 (55.6%)
Box Score
Nameless
| Player | MIN | PTS ▼ | REB | AST | STL | BLK | TOV | PF | FG | 3P | FT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1Parminder Mangat | 0 | 32 | 2 | 4 | 5 | 1 | 3 | 0 | 14-38 | 3-14 | 1-2 |
| 30HUNGYUAN CHU | 0 | 16 | 4 | 4 | 3 | 1 | 5 | 1 | 7-13 | 1-4 | 1-3 |
| 31Jingji Xu | 0 | 12 | 4 | 0 | 1 | 0 | 1 | 1 | 4-5 | 2-3 | 2-2 |
| 10Lawrence Wu | 0 | 6 | 11 | 3 | 2 | 0 | 3 | 4 | 2-10 | 0-2 | 2-3 |
| 14Bobby Mangat | 0 | 3 | 4 | 0 | 0 | 0 | 0 | 1 | 1-3 | 1-3 | 0-0 |
| 5alan zhao | 0 | 2 | 2 | 3 | 2 | 0 | 0 | 1 | 1-5 | 0-2 | 0-0 |
| 11Gao Tao | 0 | 2 | 5 | 1 | 0 | 0 | 0 | 2 | 1-2 | 0-0 | 0-0 |
| 71Wenchi Wang | 0 | 1 | 6 | 0 | 1 | 0 | 1 | 4 | 0-3 | 0-2 | 1-2 |
| TOTALS | 74 | 38 | 15 | 14 | 2 | 13 | 14 | 30-79 38.0% | 7-30 23.3% | 7-12 58.3% |
Team In The Lab
| Player | MIN | PTS ▼ | REB | AST | STL | BLK | TOV | PF | FG | 3P | FT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10Player #10 | 0 | 23 | 12 | 2 | 3 | 1 | 4 | 6 | 10-18 | 0-0 | 3-9 |
| 4Player #4 | 0 | 16 | 2 | 1 | 0 | 0 | 3 | 0 | 6-15 | 4-10 | 0-0 |
| 17Alexis Zito Ifega | 0 | 12 | 20 | 6 | 2 | 0 | 3 | 3 | 5-25 | 0-9 | 2-6 |
| 16Player #16 | 0 | 7 | 11 | 1 | 1 | 1 | 2 | 0 | 2-9 | 0-1 | 3-4 |
| 9Player #9 | 0 | 4 | 9 | 6 | 0 | 0 | 9 | 2 | 2-6 | 0-4 | 0-0 |
| 22Player #22 | 0 | 3 | 2 | 0 | 0 | 0 | 0 | 1 | 1-3 | 0-1 | 1-2 |
| 33Player #33 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1-1 | 1-1 | 0-0 |
| 45Player #45 | 0 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 1-3 | 0-2 | 0-0 |
| 999Player #999 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0-0 | 0-0 | 1-1 |
| 20Player #20 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0-1 | 0-0 | 0-0 |
| 6Player #6 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 1 | 0-3 | 0-1 | 0-0 |
| 99Player #99 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0-1 | 0-0 | 0-0 |
| TOTALS | 71 | 65 | 17 | 6 | 2 | 24 | 14 | 28-85 32.9% | 5-29 17.2% | 10-22 45.5% |